The Global Alliance for TB Drug Development (TB Alliance) and Novartis Institute for Tropical Diseases (NITD) announced their plans to
Policy discussions on new drugs and R&D have taken on new urgency because of recent policy papers and upcoming key
The TB Alliance is teaming up with researchers at the University of Illinois at Chicago (UIC) College of Pharmacy to
A class of drug, which is currently used to fight respiratory tract infections, has demonstrated pharmacological features and potential antibacterial
SAC Member Wins Prestigious Award Dr. Ramesh Panchagnula, Ph.D., member of the Global Alliance for TB Drug Development’s Scientific Advisory
NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership
New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the
Each year, the international TB community gathers together at the UNION World Conference on Lung Health to discuss TB and
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
